Overview
- An internal audit launched on May 28 flagged a sharp rise in Urology drug spending, which led KGMU to open a formal probe into Asadhya Yojana medicine use.
- University records show monthly expenditure rose from about Rs 10 lakh in Oct–Nov 2025 to roughly Rs 40 lakh in February 2026 and about Rs 45 lakh in March 2026, and investigators estimate alleged misuse near Rs 2 crore.
- The inquiry found repeated and implausible entries for high‑cost injections that cost about Rs 8,000–10,000 per dose and that medical norms say are not given so frequently.
- KGMU has relieved contractual medicine‑counter staff, removed Urology head Dr Apul Goel from his administrative post, suspended pharmacist Arshad Wasi, terminated three outsourced employees and lodged a police complaint while starting recovery proceedings.
- The probe has raised questions about internal controls and outsourcing oversight for the state scheme that provides free treatment to poor patients, and a criminal investigation and any formal recoveries remain pending.